About Izotropic Corp. 
Izotropic Corp.
Pharmaceuticals & Biotechnology
Izotropic Corporation (Izotropic) is a Canada-based company, which is engaged in commercialization of breast imaging technology for early diagnosis of breast cancer. The Company’s breast computed tomography (CT) imaging system produces breast images in three-dimensional (3D). Izotropic’s imaging system identifies tumors and determines their size, shape, location and depth. The Company makes use of cone-beam computed tomography technology to scan only the breast of interest. Izotropic’s platform computer processes raw images to reconstruct 3D images and allows radiologists to view the breast anatomy from any angle. It also offers a maximum-intensity projection (MIP) viewing capability and zoom capability on a region of interest (ROI).
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Apr 2025)
Net Profit:
-1 Million
Pharmaceuticals & Biotechnology
CAD 28 Million ()
NA (Loss Making)
NA
0.00%
-0.53
49.31%
-5.25






